Chinese(GB)     
Contact CFDA
   
HOME ABOUT CFDA WHAT'S NEW LAWS & REGULATIONS REGULATORY GUIDE DATA SEARCH SITE MAP
  Search      
Home >> What's New  
What's New
2016 Annual Report for National Adverse Drug Reaction Monitoring released
2017-05-02

On April 28, 2017, China Food and Drug Administration released the 2016 Annual Report for National Adverse Drug Reaction Monitoring. The Annual Report consists of four parts, namely: the progress of China's adverse drug reaction (ADR) monitoring in 2016, the situation of ADR reporting, the risk control measures, and five focused on aspects.

In 2016, China's national ADR monitoring continuously and effectively carried out; the number of ADR case reports further increased; the ability of analysis and evaluation gradually improved; and the capability of warning and disposal continuously strengthened. National ADR monitoring played an important role in ensuring drug safety for the public and advancing drug safety supervision.

HOME | ABOUT CFDA | WHAT'S NEW | LAWS AND REGULATIONS | REGULATORY GUIDE | DATA SEARCH
| SITE MAP |
© CFDA
Constructed and Maintained by the Information Center of CFDA